His more recent major research interest is in clinical trials of new agents in the management of lung cancer and mesothelioma. He is the author of over 145 publications, has given numerous national and international presentations, both invited and selected from abstract submission, and is actively involved in the lung cancer community. He chaired the scientific advisory committee of the Australasian Lung Cancer Trials Group between 2004 and 2011, and was the conference Co-President for the 15th World Conference on Lung Cancer held in Sydney in 2013. He is currently a member of the Board of Directors of the International Association for the Study of Lung Cancer.